Short Interest in Bionomics Limited (NASDAQ:BNOX) Grows By 335.7%

Bionomics Limited (NASDAQ:BNOX) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 647,500 shares, a growth of 335.7% from the July 15th total of 148,600 shares. Based on an average daily trading volume, of 980,900 shares, the days-to-cover ratio is presently 0.7 days.

Bionomics Stock Down 6.4 %

Shares of BNOX stock traded down $0.04 during trading hours on Wednesday, hitting $0.57. The company’s stock had a trading volume of 319,795 shares, compared to its average volume of 513,480. The business has a fifty day moving average of $0.71 and a 200-day moving average of $0.92. Bionomics has a twelve month low of $0.50 and a twelve month high of $6.41.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and set a $8.00 target price on shares of Bionomics in a research report on Thursday, August 1st.

Bionomics Company Profile

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.